ClinicalTrials.Veeva

Menu

The Outcomes of Living Donor Robotic Assisted Kidney Transplantation (RAKT)

S

Sichuan University

Status

Enrolling

Conditions

Kidney Transplant; Complications
Renal Failure Chronic

Study type

Observational

Funder types

Other

Identifiers

NCT06577805
WestChina-RAKT

Details and patient eligibility

About

The technology for robot-assisted kidney transplantation (RAKT) has become increasingly advanced, with numerous studies demonstrating comparable outcomes between RAKT surgery and open surgery. This advancement is particularly noteworthy as it extends its suitability to transplant patients with obesity. It will be important to explore the results of robot-assisted kidney transplantation as compared with open surgery or within cohorts.

Enrollment

400 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. living-donor kidney transplant recipients
  2. receiving standard triad immunosuppressive regimen

Exclusion criteria

  1. active infection
  2. multi-organ transplantation
  3. malignancy history in the donor and recipient
  4. human immunodeficiency virus infection

Trial design

400 participants in 2 patient groups

grafts with a single artery (GSA)
Description:
recipients of grafts with a single artery undergoing living donor robotic-assisted kidney transplantation
grafts with multiple single arteries (GMA)
Description:
recipients of grafts with multiple renal arteries undergoing living donor robotic-assisted kidney transplantation

Trial contacts and locations

1

Loading...

Central trial contact

Tao Lin, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems